Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00164814
Status:
TERMINATED
Last Update Posted:
2008-03-26
First Post:
2005-09-09
Brief Title:
The Role of Visceral Hyperalgesia Gastroesophageal Reflux Disease GERD and Esophageal Motility Disorder EMD in NCCP Patients
Sponsor:
Chinese University of Hong Kong
Organization:
Chinese University of Hong Kong
Study Overview
Official Title:
Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pian in Chinese Part I The Role of Visceral Hyperalgesia Gastroesophageal Reflux Disease GERD and Esophageal Motility Disorder EMD in NCCP Patients
Status:
TERMINATED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Funding ended
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Noncardiac chest pain NCCP is a common clinical problem worldwide In Hong Kong it has been estimated that about 20 of patients with chest pain are misdiagnosed to have coronary heart disease Despite its benign nature this condition causes anxiety impairs quality of life and consumes a substantial amount of healthcare resources While acid reflux and motility disorder in the esophagus are often attributed as the cause of NCCP visceral hyperalgesia of esophagus is now recognized to play a central role in the pathogenesis of this condition This research project aims to evaluate the role of visceral hyperalgesia in Chinese patients with NCCP NCCP patients will be evaluated for the prevalence of gastroesophageal reflux disease and esophageal motility disorder by endoscopy manometry and pH study The visceral sensory and pain thresholds of these patients will be compared with asymptomatic controls
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None